- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Growth Potential Companies
U.S. Pharmaceuticals & Biotech High Growth Potential Companies
UPDATED Mar 18, 2024
Companies with a Future performance score of at least 3, ordered by Future performance score.
164 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
AUPH | US$5.09 | -5.2% | -44.8% | US$736.1m | US$10.57 | PS4.2x | E53.7% | n/a | ||
SNDL | US$1.49 | 12.0% | 2.1% | US$388.1m | US$3.65 | PB0.4x | E62.2% | n/a | ||
RIGL | US$1.34 | -11.3% | -5.0% | US$235.0m | US$4.46 | PS2x | E57.1% | n/a | ||
ALIM | US$4.00 | 6.1% | 143.9% | US$209.4m | US$7.33 | PS2.6x | E104.5% | n/a | ||
MNKD | US$4.62 | 0.2% | 13.5% | US$1.2b | US$7.08 | PS6.3x | E39.2% | n/a | ||
AMRX | US$5.91 | 9.9% | 313.3% | US$1.8b | US$6.81 | PB91.7x | E129.0% | 0% | ||
AKBA | US$1.89 | 31.3% | 179.2% | US$395.7m | US$4.33 | PS2x | E60.9% | n/a | ||
SLNO | US$43.08 | -2.4% | 2,032.7% | US$1.4b | US$64.33 | PB8.9x | E60.3% | n/a | ||
ATOS | US$1.29 | 7.5% | 96.9% | US$161.6m | US$4.58 | PB1.7x | E61.3% | n/a | ||
AVTR | US$25.47 | 0.8% | 21.3% | US$17.3b | US$27.20 | PE53.8x | E27.3% | n/a | ||
ILMN | US$130.14 | -6.4% | -40.8% | US$20.7b | US$159.73 | PS4.6x | E70.2% | n/a | ||
SAVA | US$21.28 | 15.4% | -18.6% | US$919.8m | US$124.00 | PB6.7x | E104.9% | n/a | ||
PCRX | US$29.29 | -5.6% | -26.2% | US$1.4b | US$45.73 | PE32.5x | E29.3% | n/a | ||
STVN | US$29.45 | 3.2% | 27.0% | US$7.8b | US$34.74 | PE49.4x | E14.4% | 0.2% | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
BHC | US$9.38 | 2.9% | 23.3% | US$3.4b | US$9.79 | PE-5.8x | E110.0% | n/a | ||
CPRX | US$16.08 | -0.1% | -2.0% | US$1.9b | US$27.00 | PE26.5x | E17.3% | n/a | ||
ANIK | US$25.27 | -2.0% | -5.1% | US$370.5m | US$30.33 | PS2.2x | E89.1% | n/a | ||
ELAN | US$15.78 | -1.5% | 69.3% | US$7.8b | US$17.09 | PS1.8x | E84.4% | n/a | ||
BTAI | US$2.74 | -5.5% | -85.5% | US$83.2m | US$7.42 | PS60.3x | E41.1% | n/a | ||
JAZZ | US$123.41 | 5.8% | -10.6% | US$7.7b | US$186.91 | PE18.5x | E15.7% | n/a | ||
SUPN | US$34.19 | 5.4% | -3.9% | US$1.9b | US$40.50 | PE1422x | E56.9% | n/a | ||
BPTH | US$4.86 | -7.4% | -83.5% | US$3.3m | US$240.00 | PB7.5x | E58.5% | n/a | ||
PAHC | US$12.48 | -1.0% | -16.1% | US$505.5m | US$10.75 | PE34.2x | E33.2% | 3.8% |